Therapy of congestive heart failure in elderly persons

Comprehensive Therapy

Volumn 23, Issue 10, 1997, Pages 639-648

  Aronow, Wilbert S ^a,b  

^a HEBREW HOSPITAL HOME   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDRALAZINE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; LOSARTAN; NITRATE; PHOSPHODIESTERASE INHIBITOR; PRAZOSIN; PROPRANOLOL; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ANGIONEUROTIC EDEMA; ARTICLE; CONGESTIVE HEART FAILURE; COUGHING; ELDERLY CARE; GLOMERULUS FILTRATION RATE; HEART AFTERLOAD; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; RASH; SODIUM RESTRICTION; SYSTEMIC VASCULAR RESISTANCE; TASTE DISORDER; WATER DEPRIVATION;

AGED; AGED, 80 AND OVER; AGING; COMBINED MODALITY THERAPY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; RISK FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0030796353     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991;121:951-957.
2. Aronow WS, Ahn C, Kronzon I, Koenigsberg M. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol. 1991;67:295-299.
3. Wong WF, Gold S, Fukuyama O, Blanchette PL. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol. 1989;63:1526-1528.
4. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol. 1990;66:1257-1259.
5. Pernenkil R, Vinson JM, Shah AS, et al. Course and prognosis in patients ≥70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol. 1997;79:216-219.
6. Gardin JM, Arnold A, Kitzman D, et al. Congestive heart failure with preserved systolic function in a large community-dwelling elderly cohort: The Cardiovascular Health Study. Am J Cardiol. 1995;25:423A. Abstract.
7. Vasan RS, Benjamin EJ, Evans JC, et al. Prevalence and clinical correlates of diastolic heart failure: Framingham Heart Study. Circulation. 1995;92(suppl I):I-666. Abstract.
8. Konstam M, Dracup K, Baker D, et al. Heart Failure: Management of Patients with Left Ventricular Systolic Dysfunction. Quick Reference Guide for Clinicians. No. 11. AHCPR Publication No. 94-0613. Rockville, MD; Agency for Health Care Policy and Research: 1994;June:1-21.
9. Aronow WS. Echocardiography should be performed in all elderly patients with congestive heart failure. J Am Geriatr Soc. 1994;42:1300-1302.
10. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
11. Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA. 1988;259:539-544.
12. Webster MWI, Fitzpatrick MA, Nicholls MG, et al. Effect on enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol. 1985;56:566-569.
13. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
14. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
15. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
16. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
17. Garg R, Yusuf S (for the Collaborative Group on ACE Inhibitor Trials). Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273: 1450-1456.
18. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
19. Ambrosioni E, Borghi C, Magnani B (for the Survival of Myocardial Infarction Long-Term Evaluation [SMILE] Study Investigators). The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med. 1995;332: 80-85.
20. Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol. 1993;71:602-604.
21. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.
22. Gogia H, Mehra A, Parikh S, et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol.. 1995;26:1575-1580.
23. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547-1552.
24. Cohn JN, Johnson G, Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: The V-HeFT Study. Circulation. 1990;81(suppl III):III-48-III-53.
25. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:1468-1475.
26. Packer M, Rouleau J, Swedberg K, et al. Effect of flosequinan on survival in chronic heart failure: preliminary results of the PROFILE study. Circulation. 1993;88(suppl I): I-301. Abstract.
27. Califf R. Presentation of the Flolan International Randomized Survival Trial at the Forty-Third Annual Scientific Session of the American College of Cardiology, March, 1994.
28. Tresch DD, McGough MF. Heart failure with normal systolic function: a common disorder in older people. J Am Geriatr Soc. 1995;43:1035-1042.
29. Lorell BH, Isoyama S, Grice WN, et al. Effects of oubain and isoproterenol on left ventricular diastolic function during low-flow ischemia in isolated, blood perfused rabbit hearts. Circ Res. 1988;63:457-467.
30. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-533.
31. Fleg JL, Gottlieb SH, Lakatta EG. Is digoxin really important in treatment of compensated heart failure?: a placebo-controlled crossover study in patients with sinus rhythm. Am J Med. 1982;73:244-250.
32. Aronow WS, Starling L, Etienne F. Lack of efficacy of digoxin in treatment of compensated congestive heart failure with third heart sound and sinus rhythm in elderly patients receiving diuretic therapy. Am J Cardiol. 1986;58:168-169.
33. Uretsky BF, Jessup M, Konstam MA, et al. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Circulation. 1990;82:774-780.
34. Cohn JN. Presentation of the VESnarinone Trial at the Sixty-Ninth Annual Scientific Session of the American Heart Association, November, 1996.
35. Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. Lancet. 1990;336:1-6.
36. Rich MW, Woods WL, Davila-Roman VG, et al. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure. J Am Geriatr Soc. 1995;43:271-274.
37. Dies F, Krell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory out-patients with chronic cardiac failure. Circulation. 1986;74(suppl II):II-38. Abstract.
38. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA. 1982; 247:1707-1714.
39. Hawkins CM, Richardson DW, Vokonas PS. Effect of propranolol in reducing mortality in older myocardial infarction patients: The Beta-Blocker Heart Attack Trial experience. Circulation. 1983;67(suppl I):I-94-I-97.
40. Gundersen T, Abrahamsen AM, Kjekshus J, et al. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Circulation. 1982;66:1179-1184.
41. Pedersen TR (for the Norwegian Multicentre Study Group). Six-year follow-up of the Norwegian Multicentre Study on timolol after acute myocardial infarction. N Engl J Med. 1985;313:1055-1058.
42. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 1986;73:503-510.
43. The Beta-Blocker Pooling Project Research Group. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomised trials in post-infarction patients. Eur Heart J. 1988;9:8-16.
44. Lichstein E, Hager WD, Gregory JJ, et al. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. J Am Coll Cardiol. 1990;16:1327-1332.
45. Aronow WS, Ahn C, Mercando AD, et al. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%. Am J Cardiol. 1994;74:267-270.
46. Kennedy HL, Brooks MM, Barker AH, et al. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol. 1994;74:674-680.
47. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
48. Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting-enzyme inhibitors. Am J Cardiol. 1997;80:207-209.
49. Elkayam U, Amin J, Mehra A, et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 1990;82:1954-1961.
50. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988;319:385-392.
51. Goldstein RE, Boccuzzi SJ, Cruess D, et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation. 1991;83:52-60.
52. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107-1114.
53. Cohn JN, Ziesche SM, Loss LE, et al. Effect of felodipine on short-term exercise and neurohormone and long-term mortality in heart failure: results of V-HeFT III. Circulation. 1995;92(suppl I):I-143. Abstract.
54. Setaro JF, Zaret BL, Schulman DS, et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol. 1990;66:981-986.
55. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333:1190-1195.